Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.90
+0.12 (+0.42%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding Stocks
Today 9:15 EDT
Before interest rates come down, you may want to consider loading up on these terrific income stocks.
Via
The Motley Fool
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,...
Via
Benzinga
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
August 22, 2024
The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to...
Via
Benzinga
Exposures
COVID-19
Product Safety
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
August 22, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer's Options Frenzy: What You Need to Know
August 21, 2024
Via
Benzinga
Is Pfizer Stock Ready to Bounce Back?
August 18, 2024
The stock won't stay down forever.
Via
The Motley Fool
These 3 Stocks Pay You More Than 5% to Own Them
August 22, 2024
High dividend yields paired with fundamentally sound and undervalued stocks provide opportunities for both income and long-term capital appreciation.
Via
MarketBeat
Mr. Darren Walker, Dr. Albert Bourla, and Secretary General Jens Stoltenberg to be awarded Concordia Leadership Award at the 2024 Annual Summit this September
August 22, 2024
NEW YORK, N.Y., Aug. 22, 2024 (SEND2PRESS NEWSWIRE) -- The Concordia Leadership Council is proud to announce the recipients of the 2024 Leadership Award: Mr. Darren Walker, President of the Ford...
Via
Send2Press
Value Investing: Unearthing 3 Hidden Gems in Today's Market
August 21, 2024
Discover undervalued companies and build long-term wealth through the insightful strategy of value investing.
Via
MarketBeat
Pfizer, Conagra Brands And 2 Other Stocks Insiders Are Selling
August 15, 2024
Via
Benzinga
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
August 20, 2024
Global big pharmaceutical company Merck & Co. Inc. (NYSE: MRK) shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates,
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
2 Cheap Passive Income Stocks to Buy Now
August 20, 2024
Passive income stocks offer potential for steady returns and financial security in retirement.
Via
The Motley Fool
3 Top Value Stocks to Buy Right Now
August 20, 2024
Value stocks offer potential for significant returns in today's overheated market.
Via
The Motley Fool
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
August 19, 2024
Its 12-month relative strength performance is impressive, but Novavax now faces resistance.
Via
Investor's Business Daily
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
August 19, 2024
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
Product Safety
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
August 19, 2024
Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release.
Via
MarketBeat
Exposures
COVID-19
Product Safety
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
August 19, 2024
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.
Via
The Motley Fool
3 Dividend Stocks to Double Up On Right Now
August 17, 2024
How does a 5.7% dividend yield sound?
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
August 17, 2024
These cheap stocks might not be cheap for too much longer.
Via
The Motley Fool
Why Pfizer Stock Slumped on Friday
August 16, 2024
Investors were cautiously pessimistic about the latest news coming out of the company's lab.
Via
The Motley Fool
Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark
August 16, 2024
The company is now considering whether it needs to change up the vaccine to pass muster.
Via
Investor's Business Daily
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
August 16, 2024
Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of two primary immunogenicity objectives. Adjustments are planned to improve...
Via
Benzinga
Exposures
COVID-19
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
August 16, 2024
A Florida State Court sided with GSK, dismissing expert testimonies that linked ranitidine to prostate cancer, reflecting a broader scientific consensus that there is no consistent evidence supporting...
Via
Benzinga
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
August 16, 2024
From
Pfizer Inc.
Via
Business Wire
Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
August 14, 2024
On Thursday, Eli Lilly and Company (NYSE: LLY) reported its second quarter results, smashing estimates fueled by the popularity of its blockbuster diabetes drug Mounjaro and weight loss injection...
Via
Benzinga
7 Dependable Dividend Stocks for Long-Term Income
August 14, 2024
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
Via
InvestorPlace
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
August 14, 2024
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Via
InvestorPlace
3 Top Investing Opportunities During Stock Market Chaos
August 13, 2024
These stocks look like some of the top investing opportunities to buy on the recent dip that has the broader investment class worried.
Via
InvestorPlace
7 Divine Dividend Stocks to Buy for Another Market Crash
August 13, 2024
Dividend stocks have proved remarkably resilient even during severe market downturns, making them perfect additions to your portfolio.
Via
InvestorPlace
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
August 13, 2024
COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.